Allurion Technologies Announces 1-for-25 Reverse Stock Split Effective January 3
Allurion Technologies Announces 1-for-25 Reverse Stock Split Effective January 3
Allurion Technologies, Inc. (NYSE:ALUR) ("Allurion" or the "Company"), a company dedicated to ending obesity, today announced that its Board of Directors has determined to effect a one-for-twenty five reverse stock split of the Company's common stock, par value $0.0001 per share (the "Common Stock").
Allurion Technologies, Inc. (纽交所:ALUR)（"Allurion"或"公司"）是一家致力于终结肥胖的公司，今天宣布其董事会已决定对公司普通股进行1比25的反向拆股，每股面值为$0.0001（即"普通股"）。
The reverse stock split will take effect at 12:01 a.m. Eastern Time on January 3, 2025, and the Company's Common Stock will begin trading on a split-adjusted basis on The New York Stock Exchange ("NYSE") as of the opening of trading on January 3, 2025. The CUSIP number of 02008G 201 will be assigned to the Company's Common Stock when the reverse stock split becomes effective.
反向拆股将于2025年1月3日东部时间凌晨12:01生效，公司普通股将在2025年1月3日开盘时在纽约证券交易所（"纽交所"）开始以拆股调整后的基础进行交易。当反向拆股生效时，公司普通股将分配CUSIP编号02008G 201。
When the reverse stock split becomes effective, every twenty five (25) of the Company's issued shares of Common Stock will be combined into one (1) issued share of Common Stock, without any change to the par value per share. This will reduce the number of outstanding shares of Common Stock from approximately 67,781,585 million shares to approximately 2,711,263 million shares.
当反向拆股生效时，公司已发行的每25股普通股将合并为1股普通股，面值不变。这将使流通的普通股从大约6778158500万股减少到大约271126300万股。
